Anticancer drug development clinical (21 Ergebnisse)

Hardcover. Zustand: Very Good. No Jacket. Former library book; May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.

XIV, 377 p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Gestempelt. Sprache: Englisch.

hardcover. Zustand: Sehr gut. 465 Seiten; 9781588292285.2 Gewicht in Gramm: 2.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

hardcover. Zustand: New. In shrink wrap. Looks like an interesting title.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Taschenbuch. Zustand: Neu. Neuware.

Zustand: New.

Zustand: As New. Unread book in perfect condition.

Zustand: New. pp. xiv + 378.

Zustand: New.

Taschenbuch. Zustand: Neu. Anticancer Drug Development Guide | Preclinical Screening, Clinical Trials, and Approval | Beverly A. Teicher | Taschenbuch | Cancer Drug Discovery and Development | xii | Englisch | 2013 | Humana | EAN 9781461581543 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.…

Hardback. Zustand: New.

hardcover. Zustand: Sehr gut. Gebraucht - Sehr gut SG - leichte Beschädigungen oder Verschmutzungen, ungelesenes Mängelexemplar, gestempelt - Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response provides the most comprehensive body of knowledge available on the role of genetic and genomic variation in the individualization of drug therapies in cancer patients. As a consequence of the intrinsic chromosomal and genetic instability of the tumor genome, it is generally believed that tailoring of chemotherapy in cancer - tients might be achieved by molecular analysis of patient tumor DNA. In addition, to reduce the toxicity risk of patients, the tumor DNA information should be in- grated with the available data on polymorphic drug-metabolizing enzyme and tra- porter genes mediating the exposure of patients to active drugs and/or their active metabolites. The chapters of this book clearly show how DNA information from both the host (germline) and the tumor should be taken into account for rational selection of drug therapies in cancer patients, an aspect that received little attention, despite its importance. The availability of new molecular approaches to the selection of drug therapy is an emerging need, because the traditional approach based on the evaluation of patient and tumor characteristics is clearly far from optimal. Many treated patients do not experience signi cant bene ts from the treatment, while they often experience moderate to severe toxicities. In addition, the development and clinical use of novel molecularly targeted agents (alone or in combination with classical cytotoxic therapy) requires the und- standing of the molecular features of the tumors and the identi cation of tumor markers of response.…

Hardcover. Zustand: Brand New. 241 pages. 11.00x8.50x0.75 inches. In Stock.

Taschenbuch. Zustand: Neu. Anticancer Drug Development Guide | Preclinical Screening, Clinical Trials, and Approval | Beverly A. Teicher (u. a.) | Taschenbuch | Cancer Drug Discovery and Development | xiv | Englisch | 2012 | Humana | EAN 9781468498417 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.…

Zustand: Used. pp. xiv + 378.

Paperback. Zustand: Brand New. reprint edition. 465 pages. 9.75x7.00x1.25 inches. In Stock.

Hardback. Zustand: New.

Paperback. Zustand: Brand New. 392 pages. 10.20x7.60x1.10 inches. In Stock.

Hardcover. Zustand: New. Language:Chinese.HardCover. Pub Date: 2019-08-01 Publisher: People's Health Publishing House book of traditional Chinese medicine treatment is treatment of cancer from the viewpoint of innovation proposed combination of Chinese and Western medicine molecular compatibility concept research and development of new drugs. proposed to eliminate Sanjie clinical. Quxie righting the treatment of cancer; pharmaceutical research in recent years -elemene collection. the results of basic research. clinic.…